UNSPSC 51384534: Dexibuprofen

This classification denotes an ibuprofen analog and nonsteroidal anti-inflammatory agent with the molecular formula C13H18O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 671DKG7P5S, chemically known as benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (s)- but more generally known as dexibuprofen, which bears U.S. National Institutes of Health Compound Identifier 39912. European Medicines Agency schedules Dexibuprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07030MIG.

World Health Organization schedules dexibuprofen in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. DEXIBUPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51384534 Dexibuprofen is a Commodity code that nominally covers nonsteroidal anti-inflammatory medications, yet the recent state and local opportunities posted under it do not align with this scope. The most recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and drug deactivation systems for community health support, which falls outside the dexibuprofen category entirely. This mismatch suggests either a tagging error in the source data or a jurisdictional misclassification of the procurement code.

No recent state and local solicitations for dexibuprofen or comparable anti-inflammatory pharmaceuticals appear in the available opportunities block. The code shows little relevant recent activity under its actual scope. Procurement professionals evaluating this Commodity code should verify the correct UNSPSC classification for pain management and anti-inflammatory products through their state or local procurement office's taxonomy guidance before pursuing opportunities listed under this code.